Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype
Abstract Background Acute myeloid leukemia (AML) patients with normal karyotype (NK-AML) have significant variabilities in outcomes. The European Leukemia Net stratification system and some prognostic models have been used to evaluate risk stratification. However, these common standards still have s...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-12-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-022-03831-8 |
| _version_ | 1797977281824555008 |
|---|---|
| author | Yu Liu Yufei Chen Yajun Liu Mengya Li Yu Zhang Luyao Shi Lu Yang Tao Li Yafei Li Zhongxing Jiang Yanfang Liu Chong Wang Shujuan Wang |
| author_facet | Yu Liu Yufei Chen Yajun Liu Mengya Li Yu Zhang Luyao Shi Lu Yang Tao Li Yafei Li Zhongxing Jiang Yanfang Liu Chong Wang Shujuan Wang |
| author_sort | Yu Liu |
| collection | DOAJ |
| description | Abstract Background Acute myeloid leukemia (AML) patients with normal karyotype (NK-AML) have significant variabilities in outcomes. The European Leukemia Net stratification system and some prognostic models have been used to evaluate risk stratification. However, these common standards still have some limitations. The biological functions and mechanisms of Small Integral Membrane Protein 3 (SMIM3) have seldomly been investigated. To this date, the prognostic value of SMIM3 in AML has not been reported. This study aimed to explore the clinical significance, biological effects and molecular mechanisms of SMIM3 in AML. Methods RT-qPCR was applied to detect the expression level of SMIM3 in bone marrow specimens from 236 newly diagnosed adult AML patients and 23 healthy volunteers. AML cell lines, Kasumi-1 and THP-1, were used for lentiviral transfection. CCK8 and colony formation assays were used to detect cell proliferation. Cell cycle and apoptosis were analyzed by flow cytometry. Western blot was performed to explore relevant signaling pathways. The biological functions of SMIM3 in vivo were validated by xenograft tumor mouse model. Survival rate was evaluated by Log-Rank test and Kaplan–Meier. Cox regression model was used to analyze multivariate analysis. The correlations between SMIM3 and drug resistance were also explored. Results Through multiple datasets and our clinical group, SMIM3 was shown to be significantly upregulated in adult AML compared to healthy subjects. SMIM3 overexpression conferred a worse prognosis and was identified as an independent prognostic factor in 95 adult NK-AML patients. Knockdown of SMIM3 inhibited cell proliferation and cell cycle progression, and induced cell apoptosis in AML cells. The reduced SMIM3 expression significantly suppressed tumor growth in the xenograft mouse model. Western blot analysis showed downregulation of p-PI3K and p-AKT in SMIM3-knockdown AML cell lines. SMIM3 may also be associated with some PI3K-AKT and first-line targeted drugs. Conclusions SMIM3 was highly expressed in adult AML, and such high-level expression of SMIM3 was associated with a poor prognosis in adult AML. Knockdown of SMIM3 inhibited the proliferation of AML through regulation of the PI3K-AKT signaling pathway. SMIM3 may serve as a potential prognostic marker and a therapeutic target for AML in the future. |
| first_indexed | 2024-04-11T05:04:23Z |
| format | Article |
| id | doaj.art-9b7920886d584834965c2d99c9d570bb |
| institution | Directory Open Access Journal |
| issn | 1479-5876 |
| language | English |
| last_indexed | 2024-04-11T05:04:23Z |
| publishDate | 2022-12-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Translational Medicine |
| spelling | doaj.art-9b7920886d584834965c2d99c9d570bb2022-12-25T12:27:33ZengBMCJournal of Translational Medicine1479-58762022-12-0120111510.1186/s12967-022-03831-8Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotypeYu Liu0Yufei Chen1Yajun Liu2Mengya Li3Yu Zhang4Luyao Shi5Lu Yang6Tao Li7Yafei Li8Zhongxing Jiang9Yanfang Liu10Chong Wang11Shujuan Wang12Department of Hematology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Hematology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Orthopaedics, Warren Alpert Medical School/Rhode Island Hospital, Brown UniversityDepartment of Hematology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Hematology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Hematology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Hematology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Hematology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Hematology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Hematology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Hematology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Hematology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Hematology, The First Affiliated Hospital of Zhengzhou UniversityAbstract Background Acute myeloid leukemia (AML) patients with normal karyotype (NK-AML) have significant variabilities in outcomes. The European Leukemia Net stratification system and some prognostic models have been used to evaluate risk stratification. However, these common standards still have some limitations. The biological functions and mechanisms of Small Integral Membrane Protein 3 (SMIM3) have seldomly been investigated. To this date, the prognostic value of SMIM3 in AML has not been reported. This study aimed to explore the clinical significance, biological effects and molecular mechanisms of SMIM3 in AML. Methods RT-qPCR was applied to detect the expression level of SMIM3 in bone marrow specimens from 236 newly diagnosed adult AML patients and 23 healthy volunteers. AML cell lines, Kasumi-1 and THP-1, were used for lentiviral transfection. CCK8 and colony formation assays were used to detect cell proliferation. Cell cycle and apoptosis were analyzed by flow cytometry. Western blot was performed to explore relevant signaling pathways. The biological functions of SMIM3 in vivo were validated by xenograft tumor mouse model. Survival rate was evaluated by Log-Rank test and Kaplan–Meier. Cox regression model was used to analyze multivariate analysis. The correlations between SMIM3 and drug resistance were also explored. Results Through multiple datasets and our clinical group, SMIM3 was shown to be significantly upregulated in adult AML compared to healthy subjects. SMIM3 overexpression conferred a worse prognosis and was identified as an independent prognostic factor in 95 adult NK-AML patients. Knockdown of SMIM3 inhibited cell proliferation and cell cycle progression, and induced cell apoptosis in AML cells. The reduced SMIM3 expression significantly suppressed tumor growth in the xenograft mouse model. Western blot analysis showed downregulation of p-PI3K and p-AKT in SMIM3-knockdown AML cell lines. SMIM3 may also be associated with some PI3K-AKT and first-line targeted drugs. Conclusions SMIM3 was highly expressed in adult AML, and such high-level expression of SMIM3 was associated with a poor prognosis in adult AML. Knockdown of SMIM3 inhibited the proliferation of AML through regulation of the PI3K-AKT signaling pathway. SMIM3 may serve as a potential prognostic marker and a therapeutic target for AML in the future.https://doi.org/10.1186/s12967-022-03831-8Acute myeloid leukemiaPrognosisSMIM3Cell proliferationCell cyclePI3K-AKT |
| spellingShingle | Yu Liu Yufei Chen Yajun Liu Mengya Li Yu Zhang Luyao Shi Lu Yang Tao Li Yafei Li Zhongxing Jiang Yanfang Liu Chong Wang Shujuan Wang Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype Journal of Translational Medicine Acute myeloid leukemia Prognosis SMIM3 Cell proliferation Cell cycle PI3K-AKT |
| title | Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype |
| title_full | Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype |
| title_fullStr | Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype |
| title_full_unstemmed | Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype |
| title_short | Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype |
| title_sort | downregulation of smim3 inhibits growth of leukemia via pi3k akt signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype |
| topic | Acute myeloid leukemia Prognosis SMIM3 Cell proliferation Cell cycle PI3K-AKT |
| url | https://doi.org/10.1186/s12967-022-03831-8 |
| work_keys_str_mv | AT yuliu downregulationofsmim3inhibitsgrowthofleukemiaviapi3kaktsignalingpathwayandcorrelateswithprognosisofadultacutemyeloidleukemiawithnormalkaryotype AT yufeichen downregulationofsmim3inhibitsgrowthofleukemiaviapi3kaktsignalingpathwayandcorrelateswithprognosisofadultacutemyeloidleukemiawithnormalkaryotype AT yajunliu downregulationofsmim3inhibitsgrowthofleukemiaviapi3kaktsignalingpathwayandcorrelateswithprognosisofadultacutemyeloidleukemiawithnormalkaryotype AT mengyali downregulationofsmim3inhibitsgrowthofleukemiaviapi3kaktsignalingpathwayandcorrelateswithprognosisofadultacutemyeloidleukemiawithnormalkaryotype AT yuzhang downregulationofsmim3inhibitsgrowthofleukemiaviapi3kaktsignalingpathwayandcorrelateswithprognosisofadultacutemyeloidleukemiawithnormalkaryotype AT luyaoshi downregulationofsmim3inhibitsgrowthofleukemiaviapi3kaktsignalingpathwayandcorrelateswithprognosisofadultacutemyeloidleukemiawithnormalkaryotype AT luyang downregulationofsmim3inhibitsgrowthofleukemiaviapi3kaktsignalingpathwayandcorrelateswithprognosisofadultacutemyeloidleukemiawithnormalkaryotype AT taoli downregulationofsmim3inhibitsgrowthofleukemiaviapi3kaktsignalingpathwayandcorrelateswithprognosisofadultacutemyeloidleukemiawithnormalkaryotype AT yafeili downregulationofsmim3inhibitsgrowthofleukemiaviapi3kaktsignalingpathwayandcorrelateswithprognosisofadultacutemyeloidleukemiawithnormalkaryotype AT zhongxingjiang downregulationofsmim3inhibitsgrowthofleukemiaviapi3kaktsignalingpathwayandcorrelateswithprognosisofadultacutemyeloidleukemiawithnormalkaryotype AT yanfangliu downregulationofsmim3inhibitsgrowthofleukemiaviapi3kaktsignalingpathwayandcorrelateswithprognosisofadultacutemyeloidleukemiawithnormalkaryotype AT chongwang downregulationofsmim3inhibitsgrowthofleukemiaviapi3kaktsignalingpathwayandcorrelateswithprognosisofadultacutemyeloidleukemiawithnormalkaryotype AT shujuanwang downregulationofsmim3inhibitsgrowthofleukemiaviapi3kaktsignalingpathwayandcorrelateswithprognosisofadultacutemyeloidleukemiawithnormalkaryotype |